Literature DB >> 21509085

Clinically-Defined Maturity Onset Diabetes of the Young in Omanis: Absence of the common Caucasian gene mutations.

Nicholas Jy Woodhouse1, Omayma T Elshafie, Ali S Al-Mamari, Nagi Hs Mohammed, Fatma Al-Riyami, Sandy Raeburn.   

Abstract

OBJECTIVES: We are seeing a progressive increase in the number of young patients with clinically defined maturity onset diabetes of the young (MODY) having a family history suggestive of a monogenic cause of their disease and no evidence of autoimmune type 1 diabetes mellitus (T1DM). The aim of this study was to determine whether or not mutations in the 3 commonest forms of MODY, hepatic nuclear factor 4α (HNF4α), HNF1α and glucokinase (GK), are a cause of diabetes in young Omanis.
METHODS: The study was performed at Sultan Qaboos University Hospital (SQUH), Oman. Twenty young diabetics with a family history suggestive of monogenic inheritance were identified in less than 18 months; the median age of onset of diabetes was 25 years and the median body mass index (BMI) 29 at presentation. Screening for the presence of autoimmune antibodies against pancreatic beta cells islet cell antibody (ICA) and glutamic acid decarboxylase (GAD) was negative. Fourteen of them consented to genetic screening and their blood was sent to Prof. A. Hattersley's Unit at the Peninsular Medical School, Exeter, UK. There, their DNA was screened for known mutations by sequencing exon 1-10 of the GCK and exon 2-10 of the HNF1α and HNF4α genes, the three commonest forms of MODY in Europe.
RESULTS: Surprisingly, none of the patients had any of the tested MODY mutations.
CONCLUSION: In this small sample of patients with clinically defined MODY, mutations of the three most commonly affected genes occurring in Caucasians were not observed. Either these patients have novel MODY mutations or have inherited a high proportion of the type 2 diabetes mellitus (T2DM) susceptibility genes compounded by excessive insulin resistance due to obesity.

Entities:  

Keywords:  Diabetes; Diabetes Mellitus; Diabetes mellitus; MODY; Oman; Type II; Young adults; familial; maturity onset; mutations

Year:  2010        PMID: 21509085      PMCID: PMC3074660     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  18 in total

Review 1.  Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young.

Authors:  S S Fajans; G I Bell; K S Polonsky
Journal:  N Engl J Med       Date:  2001-09-27       Impact factor: 91.245

2.  ISPAD Clinical Practice Consensus Guidelines 2006-2007. The diagnosis and management of monogenic diabetes in children.

Authors:  Andrew Hattersley; Jan Bruining; Julian Shield; Pal Njolstad; Kim Donaghue
Journal:  Pediatr Diabetes       Date:  2006-12       Impact factor: 4.866

Review 3.  Genome-wide association study for type 2 diabetes: clinical applications.

Authors:  Valeriya Lyssenko; Leif Groop
Journal:  Curr Opin Lipidol       Date:  2009-04       Impact factor: 4.776

Review 4.  Clinical review: the genetics of type 2 diabetes: a realistic appraisal in 2008.

Authors:  Jose C Florez
Journal:  J Clin Endocrinol Metab       Date:  2008-09-09       Impact factor: 5.958

5.  Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1.

Authors:  A Johansen; J Ek; H B Mortensen; O Pedersen; T Hansen
Journal:  J Clin Endocrinol Metab       Date:  2005-05-31       Impact factor: 5.958

6.  Molecular Genetics of Maturity-onset Diabetes of the Young.

Authors: 
Journal:  Trends Endocrinol Metab       Date:  1999-05       Impact factor: 12.015

Review 7.  Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.

Authors:  Andrew T Hattersley; Frances M Ashcroft
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

8.  Clinical characteristics of subjects with a missense mutation in glucokinase.

Authors:  R C Page; A T Hattersley; J C Levy; B Barrow; P Patel; D Lo; J S Wainscoat; M A Permutt; G I Bell; R C Turner
Journal:  Diabet Med       Date:  1995-03       Impact factor: 4.359

9.  'I don't feel like a diabetic any more': the impact of stopping insulin in patients with maturity onset diabetes of the young following genetic testing.

Authors:  Maggie Shepherd; Andrew T Hattersley
Journal:  Clin Med (Lond)       Date:  2004 Mar-Apr       Impact factor: 2.659

10.  Genetic cause of hyperglycaemia and response to treatment in diabetes.

Authors:  Ewan R Pearson; Bryan J Starkey; Roy J Powell; Fiona M Gribble; Penny M Clark; Andrew T Hattersley
Journal:  Lancet       Date:  2003-10-18       Impact factor: 79.321

View more
  5 in total

1.  Emerging Burden of Frail Young and Elderly Persons in Oman: For whom the bell tolls?

Authors:  Hamed Al-Sinawi; Mohammed Al-Alawi; Rehab Al-Lawati; Ahmed Al-Harrasi; Mohammed Al-Shafaee; Samir Al-Adawi
Journal:  Sultan Qaboos Univ Med J       Date:  2012-04-09

Review 2.  Undiagnosed MODY: Time for Action.

Authors:  Jeffrey W Kleinberger; Toni I Pollin
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

3.  Comprehensive Maturity Onset Diabetes of the Young (MODY) Gene Screening in Pregnant Women with Diabetes in India.

Authors:  Mahesh Doddabelavangala Mruthyunjaya; Aaron Chapla; Asha Hesarghatta Shyamasunder; Deny Varghese; Manika Varshney; Johan Paul; Mercy Inbakumari; Flory Christina; Ron Thomas Varghese; Kurien Anil Kuruvilla; Thomas V Paul; Ruby Jose; Annie Regi; Jessie Lionel; L Jeyaseelan; Jiji Mathew; Nihal Thomas
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

4.  Causal variants in Maturity Onset Diabetes of the Young (MODY) - A systematic review.

Authors:  Ibrar Rafique; Asif Mir; Muhammad Arif Nadeem Saqib; Muhammad Naeem; Luc Marchand; Constantin Polychronakos
Journal:  BMC Endocr Disord       Date:  2021-11-11       Impact factor: 2.763

5.  Identification of Maturity-Onset-Diabetes of the Young (MODY) mutations in a country where diabetes is endemic.

Authors:  Hessa Al-Kandari; Dalia Al-Abdulrazzaq; Lena Davidsson; Rasheeba Nizam; Sindhu Jacob; Motasem Melhem; Sumi Elsa John; Fahd Al-Mulla
Journal:  Sci Rep       Date:  2021-08-09       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.